Viewing StudyNCT00048880



Ignite Creation Date: 2024-05-05 @ 11:26 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00048880
Status: COMPLETED
Last Update Posted: 2017-07-02
First Post: 2002-11-08

Brief Title: Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein
Sponsor: National Cancer Institute NCI
Organization: National Institutes of Health Clinical Center CC

Conditions & Keywords Data

Conditions:
Name
Neoplasms
Keywords:
Name View
Anaplastic Large Cell Lymphoma View
Monoclonal Antibody View
CD30 View
Antibody Saturation View
Apoptosis View
Flow Cytometry View
Cancer View